Pirtobrutinib | Search results

Showing 1 to 5 of 5 results for pirtobrutinib

Sort by

Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]
In development Reference number: GID-TA11501 Expected publication date: 24 February 2027
Result type
Technology appraisal guidance
Status
In development
Pirtobrutinib for treating relapsed or refractory mantle cell lymphoma untreated with a BTK inhibitor [ID6493]
Awaiting development Reference number: GID-TA11639 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
Awaiting development
Pirtobrutinib with venetoclax and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6566]
Awaiting development Reference number: GID-TA11748 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
Awaiting development
Pirtobrutinib for treating chronic lymphocytic leukaemia or small lymphocytic lymphoma after 1 or more BTK inhibitors [ID6269]
In development Reference number: GID-TA11298 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development
Pirtobrutinib for treating relapsed or refractory mantle cell lymphoma [ID3975]
In development Reference number: GID-TA10858 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development